Miss Miriam Ruiz Ballester
Foundation for Health Research and Training, Murcia (Spain)
Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55/YY1/sST2 signaling axis
Event: Heart Failure 2024
Topic: Gene Therapy, Cell Therapy
Session: ePosters in basic science 1
